
With patients buying gray-market peptides, HHS’s draft policy aims to reunite prescribers, patients, and pharmacists around these emerging products.
Alvesco approved for asthma
Prodrug ciclesonide, activated by intracellular esterases following oral inhalation, has been approved by the FDA as an inhalation aerosol for use as a prophylactic therapy in adults and adolescents aged 12 years and older with asthma. The drug is called a new generation of corticosteroid by manufacturer






